FIELD: biotechnology.
SUBSTANCE: invention relates to the biotechnology. Specifically to a method for controlling the preparation of influenza vaccine.
EFFECT: invention enables to obtain pure, effective, without extraneous impurities, vaccines for influenza type A and type B, reduce allergenicity of the produced vaccine, obtaining HPV of influenza virus having high haemagglutination activity, increase antigen output, preserve vitality and high productivity of target proteins without using controlled expression in HPV influenza cell-producers.
1 cl, 44 dwg, 15 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PRODUCING A POLYVALENT INFLUENZA VACCINE | 2018 |
|
RU2701953C1 |
| MULTIVALENT INFLUENZA VACCINE | 2018 |
|
RU2706191C1 |
| CONCENTRATE OF INFLUENZA VACCINE AND METHOD FOR ITS PREPARATION | 2018 |
|
RU2706544C1 |
| LENTIVIRUS PLASMIDA (OPTIONS), METHOD FOR ITS OBTAINING (OPTIONS), SET OF PRIMERS FOR OBTAINING LENTIVIRUS PLASMID VECTOR (OPTIONS) | 2018 |
|
RU2680537C1 |
| INFLUENZA VIRUS THE VIRUS-LIKE PARTICLE AND ITS OBTAINING METHOD | 2018 |
|
RU2681439C1 |
| FLU VIRUS PROTEINS PRODUCER MDCK CELL (OPTIONS) | 2018 |
|
RU2681482C1 |
| CASSETTE INTENDED FOR OBTAINING PLASMID VECTORS USED TO CREATE CELL PRODUCERS OF VIRUS-LIKE PARTICLES (VLP) OF INFLUENZA VIRUS | 2018 |
|
RU2680703C1 |
| STRAIN OF BACTERIA ESCHERICHIA COLI - PRODUCER OF RECOMBINANT PROTEIN NS1 | 2021 |
|
RU2789735C1 |
| CULTIVATED HYBRID CELL STRAIN OF MOUSE Mus. Musculus-1E7 PRODUCER OF MONOCLONAL ANTIBODY IMMUNORESPONSIVE TO HAEMAGGLUTININ PROTEIN OF PANDEMIC INFLUENA VIRUS A/IIV-Moscow/01/09(H1N1)sw1 | 2011 |
|
RU2457243C1 |
| OBTAINING VIRUS-LIKE PARTICLES OF INFLUENZA VIRUS IN PLANTS | 2014 |
|
RU2742607C1 |
